Kirkland & Ellis advised Novo Holdings A/S, a leading global life sciences investor, on its acquisition of Medical Knowledge Group from Court Square Capital and Aisling Capital. Medical Knowledge Group is an analytics-driven drug commercialisation platform servicing the biopharmaceutical industry. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2022. The Kirkland team was led by corporate partners Francisco Morales Barrón and David Feirstein and debt finance partners Jay Ptashek and John Ilardo.